Quantcast

ST. LOUIS RECORD

Saturday, April 27, 2024

Nicholas Malfitano News


After three initial losses, Roundup manufacturers get their first win in Philly courtroom

By Nicholas Malfitano |
PHILADELPHIA – For the very first time in Philadelphia, a jury has unanimously found in favor of the manufacturers of weed killer product Roundup, in the latest case to go to trial over allegations that product causes cancer in its users.

Philly Roundup judge slams Monsanto's attempt at relief after $175M jury verdict, adds $2.3M

By Nicholas Malfitano |
PHILADELPHIA – A Philadelphia trial court judge has upheld a $175 million verdict against the manufacturers of weed killer product Roundup, added nearly $2.3 million in delay damages to that amount and blasted the company’s challenge to the verdict amount as “unfathomable”, “stubborn” and “indignant.”

Philadelphia jury hands down $2.2B verdict in third Roundup trial, the largest ever for that product

By Nicholas Malfitano |
PHILADELPHIA – The manufacturers of weed killer Roundup have lost a third trial in Philadelphia and were hit with its largest-ever verdict at a whopping cost of $2.25 billion, not long after local juries handed down a $175 million verdict award to plaintiffs in the first case and a $3.5 million award in the second.

Philadelphia now the top-ranked 'Judicial Hellhole'; Massive verdicts, like $8B Risperdal case, cited

By Nicholas Malfitano |
WASHINGTON – In an annual report of “Judicial Hellholes” released today by the American Tort Reform Association, Philadelphia has claimed the No. 1 ranking – in part due to a historic $8 billion punitive damages verdict rendered this year in litigation connected to Johnson & Johnson’s anti-psychotic drug Risperdal.

Eight-day hearing on viability of witnesses in talc lawsuits set to conclude

By Nicholas Malfitano |
TRENTON, N.J. – Eight days of scientific expert witness testimony in a New Jersey federal court, centered on whether Johnson & Johnson’s talc-containing baby powder causes women to develop both ovarian cancer and mesothelioma, will conclude Wednesday and ultimately determine if 12,000 lawsuits on the subject move forward.

Facing 12,000 lawsuits, J&J has expert testify that there is no link between talc and ovarian cancer

By Nicholas Malfitano |
TRENTON, N.J. – The fate of about 12,000 lawsuits claiming Johnson & Johnson’s talc-containing baby powder causes women to develop both ovarian cancer and mesothelioma, will be decided after eight days of expert witness testimony in a New Jersey federal court.

No jackpot in first Philadelphia talc trial; Judge rules plaintiff has no evidence

By Nicholas Malfitano |
PHILADELPHIA – Companies facing million-dollar lawsuits in Philadelphia can celebrate today, as what would have been the first talc-related asbestos trial held in the city has seen a judge cut off the plaintiff’s case before it could ever get to a jury.